Bio-Techne (TECH) Total Debt Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.78% |
| Dec 31, 2025 | 3.02% |
| Sep 30, 2025 | -1.09% |
| Jun 30, 2025 | -0.61% |
| Mar 31, 2025 | -4.41% |
| Dec 31, 2024 | -4.77% |
| Sep 30, 2024 | -9.20% |
| Jun 30, 2024 | -8.78% |
| Mar 31, 2024 | -5.72% |
| Dec 31, 2023 | -3.90% |
| Sep 30, 2023 | -4.68% |
| Jun 30, 2023 | 0.84% |
| Mar 31, 2023 | -1.07% |
| Dec 31, 2022 | -13.62% |
| Sep 30, 2022 | -6.39% |
| Jun 30, 2022 | -8.95% |
| Mar 31, 2022 | -8.82% |
| Dec 31, 2021 | -7.78% |
| Sep 30, 2021 | -5.74% |
| Jun 30, 2021 | 30.12% |
| Mar 31, 2021 | 5.68% |
| Dec 31, 2020 | 6.59% |
| Sep 30, 2020 | 14.03% |
| Jun 30, 2020 | 37.34% |
| Mar 31, 2020 | 120.07% |
| Dec 31, 2019 | 21.61% |
| Sep 30, 2019 | 34.12% |
| Jun 30, 2019 | 135.34% |